← Back to Search

DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery (DETECT-POAF Trial)

N/A
Recruiting
Led By David Conen, MD, MPH
Research Sponsored by Population Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 35 days of non-cardiac surgery
Awards & highlights
No Placebo-Only Group

Summary

This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.

Eligible Conditions
  • Atrial Fibrillation
  • Atrial Flutter

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 35 days of non-cardiac surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 35 days of non-cardiac surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of clinically important post-operative atrial fibrillation/atrial flutter
Secondary study objectives
Multivariate odds ratio of risk factors associated with the occurrence of clinically important POAF

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study CohortExperimental Treatment1 Intervention
Participants will receive up to 14 days of continuous cardiac monitoring

Find a Location

Who is running the clinical trial?

Population Health Research InstituteLead Sponsor
164 Previous Clinical Trials
717,764 Total Patients Enrolled
33 Trials studying Atrial Fibrillation
54,374 Patients Enrolled for Atrial Fibrillation
David Conen, MD, MPHPrincipal InvestigatorPopulation Health Research Institute
2 Previous Clinical Trials
5,479 Total Patients Enrolled
2 Trials studying Atrial Fibrillation
5,479 Patients Enrolled for Atrial Fibrillation
Michael K Wang, MDPrincipal InvestigatorPopulation Health Research Institute
~500 spots leftby Aug 2026